Related Experiment Video
Updated: Oct 28, 2026
In Vitro Transcription Assays and Their Application in Drug Discovery
Published on: September 20, 2016
An in vitro transcription assay for probing drug-DNA interactions at individual drug sites
D R Phillips1, C M Cullinane, D M Crothers
1Department of Biochemistry, La Trobe University, Bundoora, Victoria, Australia.
Abstract:
An in vitro transcription assay of drug-DNA interactions has been described and is based largely on the stable lac UV5-initiated transcription complex. This system utilizes a synchronized population of radiolabeled nascent RNA 10 nucleotides long. Reaction of this initiated transcription complex with drug and subsequent elongation of the nascent RNA by Escherichia coli RNA polymerase, reveals blockages at drug binding sites. From these blockages it is possible to obtain four features of the drug-DNA interaction: the sequence of preferred drug binding sites, the relative drug occupancy at each binding site, the drug dissociation rate at each site, and the probability of drug-induced termination of transcription at each site. The unidirectional transcription assay has been extended to a two-promoter, counter-directed system, which yields a bidirectional transcription footprint of drug sites.
Insights
This study introduces a novel in vitro transcription assay to analyze drug-DNA interactions. The method maps drug binding sites and quantifies their impact on transcription, revealing key binding and termination characteristics.
Area of Science:
- Molecular Biology
- Biochemistry
- Drug Discovery
Background:
- Understanding drug-DNA interactions is crucial for developing new therapeutics.
- Existing methods for analyzing drug-DNA binding can be complex and time-consuming.
Purpose of the Study:
- To develop a novel in vitro transcription assay for characterizing drug-DNA interactions.
- To determine the sequence specificity, occupancy, dissociation rates, and termination probability of drug binding sites.
Main Methods:
- Utilized a stable lac UV5-initiated transcription complex with synchronized nascent RNA.
- Analyzed blockages in RNA elongation upon drug addition using Escherichia coli RNA polymerase.
- Extended the assay to a bidirectional system for comprehensive drug site footprinting.
Main Results:
- Identified preferred drug binding site sequences.
- Quantified relative drug occupancy and dissociation rates at identified sites.
- Determined the probability of drug-induced transcription termination.
Conclusions:
- The developed assay provides a detailed characterization of drug-DNA interactions.
- This method offers insights into drug binding kinetics and their effects on transcription.
- The bidirectional extension enhances the resolution of drug-DNA binding footprints.
More Related Videos
06:43A Quantitative Assay to Study Protein:DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
Published on: August 31, 2013
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
